Skip to main content

Table 1 Characteristics of patients enrolled in the present study

From: Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury

 

All patients (n= 76)

Survivors (n= 56)

Nonsurvivors (n= 20)

P value

Age, years, mean (SD)

55 (19)

52 (19)

62 (16)

0.04

Sex, male, n

52

40

12

0.345

Admission, n

    

   Surgical

27

20

7

0.954

   Clinical

49

36

13

 

Origin, n

    

   Ward

34

22

12

0.181

   Emergency room

42

34

8

 

Sepsis, during ICU stay, n

39

23

16

0.003

APACHE II score, points, mean (SD)

19 (8)

18 (8)

20 (8)

0.319

SOFA admission, points, mean (SD)

6.6 (4.0)

6.0 (3.4)

8.3 (4.7)

0.03

Mechanical ventilation during ICU stay, n

46

29

17

0.008

Sedation during ICU stay, n

50

32

18

0.008

Vasopressor need during ICU stay, n

31

21

10

0.329

BDNF D0 mean (SD)

4,831 (3,366)

6,861 (2,764)

5,736 (2,951)

0.129

BDNF D2, mean (SD)

5,865 (2,661)

6,741 (2,356)

3,413 (1,813)

< 0.0001

% variation BDNF, n

    

Decrease

19

8

11

0.001

No change/increase

57

48

9

 
  1. APACHE II, Acute Physiology and Chronic Health Evaluation score; BDNF D0, brain-derived neurotrophic factor collected within 12 hours of enrollment; BDNF D2, brain-derived neurotrophic factor collected 48 hours after intensive care admission; ICU, intensive care unit; SD, standard deviation; sepsis, severe sepsis and septic shock; SOFA, sequential organ-failure assessment.